What is the appropriate management for a patient with persistent scleral redness and pain after 6 days of erythromycin therapy?

Immediate Ophthalmology Referral Required

This patient requires urgent ophthalmology evaluation for suspected scleritis or infectious keratitis, as erythromycin is inappropriate for scleral disease and treatment failure after 6 days indicates either wrong diagnosis or wrong therapy.

Critical Diagnostic Distinction

The key issue here is that erythromycin topical is contraindicated for ophthalmic use 1. The FDA label explicitly states "For topical use only; not for ophthalmic use" and warns to "avoid contact with eyes and all mucous membranes" 1. This patient has been receiving inappropriate therapy.

Differential Diagnosis Priority

The persistent scleral redness and pain after 6 days suggests:

Most Likely Diagnoses:

• Scleritis (not conjunctivitis) - requires different management entirely
• Infectious scleritis - particularly if history of trauma or recent ocular surgery 2, 3
• Autoimmune scleritis - associated with systemic diseases 4

Key Clinical Distinction:

• Scleritis: Deep, boring pain; scleral hyperemia that does NOT blanch with topical phenylephrine 10% 4
• Conjunctivitis: Superficial irritation; hyperemia blanches with vasoconstrictors

Immediate Management Algorithm

Step 1: Phenylephrine Test

• Instill phenylephrine 10% topically
• If redness persists → scleritis (refer urgently)
• If redness blanches → conjunctivitis (but still treatment failure)

Step 2: Assess for Infectious Etiology

High-risk features for infectious scleritis 2, 3:

• Recent ocular surgery (58-83% of infectious scleritis cases)
• History of trauma (~10% of cases)
• Scleral necrosis on examination (93% of infectious cases)
• Worsening despite therapy

If infectious scleritis suspected:

• Requires urgent surgical debridement + antimicrobial therapy 2, 3
• Culture and sensitivity testing mandatory
• Bacterial causes (86-87%) more common than fungal (11-13%), but fungal has worse prognosis 3

Step 3: Definitive Treatment Based on Etiology

For Infectious Scleritis:

• Surgical debridement of necrotic tissue PLUS appropriate antimicrobials 2, 3
• Medical therapy alone has poor outcomes
• Early surgical intervention significantly improves globe salvage rates 3

For Autoimmune Scleritis:

• Systemic immunosuppression required 4
• Topical corticosteroids alone insufficient
• May require azathioprine or cyclophosphamide for severe cases 4

For Bacterial Conjunctivitis (if confirmed):

• Switch to appropriate ophthalmic antibiotic (fluoroquinolone drops)
• Consider gonococcal/chlamydial etiology if sexually active 5
• Ceftriaxone 1g IM + azithromycin 1g PO for gonococcal coverage 5

Critical Pitfalls to Avoid

1. Never use topical erythromycin for eye conditions - it is explicitly contraindicated for ophthalmic use 1

2. Do not treat scleritis as conjunctivitis - scleritis requires systemic therapy and has vision-threatening potential 6

3. Do not delay surgical intervention for infectious scleritis - medical therapy alone leads to poor outcomes; early debridement is critical 2, 3

4. Do not start steroids without ruling out infection - immunosuppression worsens infectious scleritis dramatically 2

5. Poor prognostic factors requiring aggressive management 3:

   • Poor visual acuity at presentation
   • Associated endophthalmitis or keratitis
   • Fungal etiology
   • Medical therapy without surgical debridement

Bottom Line

This patient needs same-day ophthalmology evaluation with slit-lamp examination, phenylephrine testing, and likely culture/biopsy if scleritis is confirmed. The use of erythromycin was inappropriate from the start, and 6 days of treatment failure mandates specialist assessment to prevent vision loss.